If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?When I last covered Travere Therapeutics, Inc. (NASDAQ: TVTX ) back in March, I gave its stock a Hold rating. I discussed the company securing an accelerated, followed by a full approval for its therapy Filspari (s ...